DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

Virtual Booth

Contact Supplier

Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

API

FDF

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

Annual Reports (USD Million)

Finished Drug Prices

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 87893-55-8, 15d-pgj2, 15-deoxy-pgj2, 15-deoxy-delta12,14-prostaglandin j2, 15-deoxy-delta-12,14-pgj2, 15-dpgj2

Molecular Formula

C₂₀H₂₈O₃

Molecular Weight

316.4 g/mol

InChI Key

VHRUMKCAEVRUBK-GODQJPCRSA-N

FDA UNII

ALI977775J

1 2D Structure

15-Deoxy-Delta12,14-Prostaglandin J2

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(Z)-7-[(1S,5E)-5-[(E)-oct-2-enylidene]-4-oxocyclopent-2-en-1-yl]hept-5-enoic acid

2.1.2 InChI

InChI=1S/C20H28O3/c1-2-3-4-5-6-10-13-18-17(15-16-19(18)21)12-9-7-8-11-14-20(22)23/h6-7,9-10,13,15-17H,2-5,8,11-12,14H2,1H3,(H,22,23)/b9-7-,10-6+,18-13+/t17-/m0/s1

2.1.3 InChI Key

VHRUMKCAEVRUBK-GODQJPCRSA-N

2.1.4 Canonical SMILES

CCCCCC=CC=C1C(C=CC1=O)CC=CCCCC(=O)O

2.1.5 Isomeric SMILES

CCCCC/C=C/C=C/1\[C@H](C=CC1=O)C/C=C\CCCC(=O)O

2.2 Other Identifiers

2.2.1 UNII

ALI977775J

2.3 Synonyms

2.3.1 MeSH Synonyms

1. 15-deoxy-12,14-prostaglandin J2

2. 15-deoxy-delta(12,14)-prostaglandin J2

3. 15-deoxy-delta(12,14)pgj2

2.3.2 Depositor-Supplied Synonyms

1. 87893-55-8

2. 15d-pgj2

3. 15-deoxy-pgj2

4. 15-deoxy-delta12,14-prostaglandin J2

5. 15-deoxy-delta-12,14-pgj2

6. 15-dpgj2

7. Delta12,14-pgj 2

8. 15-deoxy-delta12,14-pgj2

9. (5z,12e,14e)-11-oxoprosta-5,9,12,14-tetraen-1-oic Acid

10. Prosta-5,9,12,14-tetraen-1-oic Acid, 11-oxo-, (5z,12e,14e)-

11. J694.826j

12. Chembl482477

13. Chebi:34159

14. Ali977775j

15. Delta-12,14-15-deoxy-pgj2

16. 15-deoxy-delta12,14-prostaglandin

17. (z)-7-[(1s,5e)-5-[(e)-oct-2-enylidene]-4-oxocyclopent-2-en-1-yl]hept-5-enoic Acid

18. 15-deoxy-delta-12, 14 Pgj-2

19. 15-deoxy-delta(12,14)-prostaglandin J2

20. 15-deoxy-delta 12, 14-prostaglandin J2

21. 11-oxo-5z,9,12e,14e-prostatetraenoic Acid

22. 15-deoxy-

23. Currency-12,14-prostaglandin J2

24. (5z,12e,14e)-11-oxo-prosta-5,9,12,14-tetraen-1-oic Acid

25. Prosta-5,9,12,14-tetraen-1-oicacid, 11-oxo-, (5z,12e,14e)-

26. 15-deoxy-d-12,14-prostaglandin J2

27. Sr-05000002103

28. Unii-ali977775j

29. 15-deoxy-d-12,14-pgj2

30. 15d-prostaglandin J2

31. Delta12,14-pgj2

32. Spectrum5_001971

33. 15-deoxy-prostaglandin J2

34. Bspbio_001361

35. Bml2-b05

36. Gtpl2692

37. Schembl3177249

38. Dtxsid1043706

39. Hms1361e03

40. Hms1791e03

41. Hms1989e03

42. Hms3402e03

43. Hms3648l20

44. Hms3648l22

45. 15-deoxy .delta.12,14pgj2

46. .delta.12,14-pgj 2

47. Zinc5972962

48. Bdbm50270612

49. Lmfa03010021

50. 15-deoxy-d12,14-prostaglandin J2

51. 15-deoxy-?12,14-prostaglandin A2

52. Akos024457040

53. 15-deoxy-delta(12,14)-pgj2

54. 15-deoxy-?-12,14-prostaglandin J2

55. Idi1_033831

56. 11-oxo-5z,9,12,14-prostatetraenoate

57. Ncgc00161304-01

58. Ncgc00161304-02

59. Ncgc00161304-03

60. Ncgc00161304-04

61. Ncgc00161304-05

62. 15-deoxy- Delta 12,14-prostaglandin A2

63. 15-deoxy- Delta 12,14-prostaglandin J2

64. Hy-108568

65. 11-oxo-5z,9,12,14-prostatetraenoic Acid

66. 15-deoxy-.delta.12,14-prostaglandin J2

67. Cs-0029180

68. 15-deoxy-

69. Currency12,14-prostaglandin J2

70. 11-oxo-prosta-5z,9,12e,14e-tetraen-1-oic Acid

71. 15-deoxy- Delta 12,14-prostaglandin J2 Solution

72. J-002852

73. Sr-05000002103-2

74. Sr-05000002103-3

75. Brd-k05396879-001-02-6

76. Q27070775

77. (5z,12e,14e) 11-oxo Prosta-5,9,12,14-tetraen-1-oate

78. (5z,12e,14e)-11-oxo-prosta-5,9,12,14-tetraen-1-oate

79. (5z,12e,14e) 11-oxo Prosta-5,9,12,14-tetraen-1-oic Acid

80. Prosta-5,9,12,14-tetraen-1-oic Acid, 11-oxo (5z,12e,14e)

81. 7-((s)-5-(oct-2-enylidene)-4-oxocyclopent-2-enyl)hept-5-enoic Acid

82. Prosta-5,9,12,14-tetraen-1-oic Acid, 11-oxo-, (5z,12e,14e)- (9ci)

83. (z)-7-[(1s,5e)-5-[(e)-oct-2-enylidene]-4-oxo-1-cyclopent-2-enyl]hept-5-enoic Acid

84. (z)-7-[(1s,5e)-5-[(e)-oct-2-enylidene]-4-oxo-cyclopent-2-en-1-yl]hept-5-enoic Acid

85. 15-deoxy-delta12,14-prostaglandin J2, >=95% (hplc), 1 Mg/ml In Methyl Acetate

86. 87-57-0

2.4 Create Date

2005-06-01

3 Chemical and Physical Properties

Molecular Formula	C₂₀H₂₈O₃
Molecular Weight	316.4 g/mol
XLogP3	5
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	3
Rotatable Bond Count	11
Exact Mass	316.20384475 g/mol
Monoisotopic Mass	316.20384475 g/mol
Topological Polar Surface Area	54.4 Å²
Heavy Atom Count	23
Formal Charge	0
Complexity	495
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	3
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Pharmacology and Biochemistry

4.1 MeSH Pharmacological Classification

Immunologic Factors

Biologically active substances whose activities affect or play a role in the functioning of the immune system. (See all compounds classified as Immunologic Factors.)

ABOUT THIS PAGE

Find 15-Deoxy-Delta12,14-Prostaglandin J2 manufacturers, exporters & distributors on PharmaCompass

15-Deoxy-Delta12,14-Prostaglandin J2

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

API REF. PRICE (USD/KG)

$ 0

MARKET PLACE

0INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

0 DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

PATENTS & EXCLUSIVITIES

DIGITAL CONTENT

GLOBAL SALES INFORMATION

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

What are you looking for?